Foam treatment for atopic dermatitis
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This trial tests a new foam medication for adults with atopic dermatitis (a type of eczema). It aims to see if the foam is better than a placebo (a foam with no active ingredient) at treating the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have atopic dermatitis (eczema) diagnosed by a doctor using standard criteria.
- You have had eczema for at least 3 years.
- Your eczema covers 5% to 40% of your body (not counting your scalp).
- Your eczema is mild to moderate, as rated by a doctor on a scale of 0 to 4 (score of 2 or 3).
- You have not had a sudden flare-up of eczema or contact dermatitis in the last 28 days.
- You have not used the study medication (OPA-15406 ointment) before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new foam medicine for children and infants with mild-to-moderate eczema (atopic dermatitis). The foam is applied to the skin to help reduce symptoms and improve the condition.
This study tests a new cream called JYP0066 for people with mild-to-moderate atopic dermatitis (eczema). It aims to see if the cream safely reduces itching and skin inflammation. It might help if you have tried other creams and still have symptoms.
This study tests a new medication called PRA-216 for atopic dermatitis (a skin condition also known as eczema). It aims to see how safe and effective it is for people who haven't had success with topical treatments.
This trial tests a study drug (PF-08049820) for people with moderate to severe eczema who haven't found a suitable prescription treatment. It aims to see if the drug can improve skin symptoms and itching.
This study tests a new ointment called IN-115314 for adults with mild to moderate eczema. Researchers want to see if it helps control symptoms like itching and redness better than a placebo, and check that it's safe to use.
This trial tests a new gel called PG-011 for people with mild to moderate eczema (atopic dermatitis). The gel is applied to the skin, and the study will check if it helps improve symptoms safely.
Hear when a new Atopic Dermatitis (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.